TD Cowen upgrades Booz Allen Hamilton stock rating on backlog growth
TD Cowen upgraded Booz Allen Hamilton (BAH) to Buy, raising its price target to $95. The firm cited improving backlog growth, stable federal civilian sales, and fixed-price trends. BAH's September quarter funded backlog was $5.7B, up sequentially. The company recently reported Q2 adjusted EPS of $1.76, beating estimates, though revenue missed slightly. BAH raised its full-year EPS and EBITDA guidance, highlighting strong cash flow and backlog growth.
How this was made
The 30-second read
Why it matters
The combination of an earnings beat and a strong backlog supports the analyst's bullish outlook.
Market read
The upgrade and earnings beat provide a clear catalyst for short‑term buying interest in BAH.
What to watch
Potential headwinds from Treasury de‑scope and PTEMS rebid losses may limit upside.
Background
Booz Allen Hamilton reported Q2 results with EPS beat but slight revenue miss, while its funded backlog rose to $5.7 bn.
Ticker impact
TD Cowen upgraded Booz Allen Hamilton to Buy and raised its price target to $95, citing funded backlog growth and an earnings beat.
potential upside as the market prices in the upgrade and earnings beat
Analyst upgrade with a higher target and better‑than‑expected earnings typically drive buying pressure.
Market effects
Positive signal for the defense consulting sector as backlog growth may indicate broader demand.
U.S. defense and government‑contracting stocks could see modest gains.
Limited to U.S. markets; no direct global impact.
Counterpoint
If backlog growth stalls or federal civilian sales weaken further, the upgrade could be premature.
Key entities
- AnalystTD Cowen
Upgraded Booz Allen Hamilton to Buy and raised price target.
- CompanyBooz Allen Hamilton
Defense consulting firm reporting Q2 results.


